VIA Labs, Inc. Logo

VIA Labs, Inc.

6756.TW

(1.5)
Stock Price

138,00 TWD

5.14% ROA

6.68% ROE

64.08x PER

Market Cap.

12.140.663.000,00 TWD

8.54% DER

1.14% Yield

9.68% NPM

VIA Labs, Inc. Stock Analysis

VIA Labs, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

VIA Labs, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

The stock's ROE falls within an average range (9.31%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (8.28%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 Dividend

The company's history of regular dividend distributions in the last three years showcases its ability to generate reliable income for shareholders.

5 Buffet Intrinsic Value

The company's stock seems undervalued (2.089) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.53x) suggests it's overvalued, potentially making it an expensive investment.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

VIA Labs, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

VIA Labs, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

VIA Labs, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

VIA Labs, Inc. Revenue
Year Revenue Growth
2016 826.661.000
2017 1.186.018.000 30.3%
2018 1.201.510.000 1.29%
2019 1.585.688.000 24.23%
2020 1.969.592.000 19.49%
2021 3.367.047.000 41.5%
2022 2.954.986.000 -13.94%
2023 2.230.484.000 -32.48%
2023 2.035.103.000 -9.6%
2024 1.980.112.000 -2.78%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

VIA Labs, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2016 358.363.000
2017 377.355.000 5.03%
2018 394.011.000 4.23%
2019 452.264.000 12.88%
2020 487.765.000 7.28%
2021 650.767.000 25.05%
2022 714.750.000 8.95%
2023 612.284.000 -16.74%
2023 506.716.000 -20.83%
2024 490.268.000 -3.35%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

VIA Labs, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2016 17.299.000
2017 19.122.000 9.53%
2018 28.233.000 32.27%
2019 38.138.000 25.97%
2020 46.076.000 17.23%
2021 59.882.000 23.06%
2022 73.380.000 18.39%
2023 91.124.000 19.47%
2023 76.255.000 -19.5%
2024 67.372.000 -13.19%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

VIA Labs, Inc. EBITDA
Year EBITDA Growth
2016 45.734.000
2017 143.960.000 68.23%
2018 144.116.000 0.11%
2019 309.159.000 53.38%
2020 403.318.000 23.35%
2021 1.113.119.000 63.77%
2022 978.931.000 -13.71%
2023 509.272.000 -92.22%
2023 296.027.000 -72.04%
2024 399.684.000 25.93%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

VIA Labs, Inc. Gross Profit
Year Gross Profit Growth
2016 433.609.000
2017 568.163.000 23.68%
2018 589.426.000 3.61%
2019 821.820.000 28.28%
2020 960.842.000 14.47%
2021 1.794.945.000 46.47%
2022 1.546.092.000 -16.1%
2023 993.440.000 -55.63%
2023 792.454.000 -25.36%
2024 860.920.000 7.95%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

VIA Labs, Inc. Net Profit
Year Net Profit Growth
2016 3.648.000
2017 95.904.000 96.2%
2018 123.912.000 22.6%
2019 242.819.000 48.97%
2020 318.484.000 23.76%
2021 880.311.000 63.82%
2022 723.535.000 -21.67%
2023 309.456.000 -133.81%
2023 180.569.000 -71.38%
2024 209.088.000 13.64%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

VIA Labs, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2016 0
2017 2 100%
2018 2 0%
2019 4 50%
2020 5 20%
2021 13 61.54%
2022 11 -30%
2023 4 -150%
2023 3 -100%
2024 3 33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

VIA Labs, Inc. Free Cashflow
Year Free Cashflow Growth
2016 -51.565.000
2017 186.233.000 127.69%
2018 99.308.000 -87.53%
2019 163.062.000 39.1%
2020 245.909.000 33.69%
2021 819.372.000 69.99%
2022 76.149.000 -976.01%
2023 262.392.000 70.98%
2023 842.025.000 68.84%
2024 172.699.000 -387.57%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

VIA Labs, Inc. Operating Cashflow
Year Operating Cashflow Growth
2016 -44.180.000
2017 194.161.000 122.75%
2018 118.702.000 -63.57%
2019 194.638.000 39.01%
2020 317.561.000 38.71%
2021 897.261.000 64.61%
2022 210.327.000 -326.6%
2023 296.851.000 29.15%
2023 1.007.234.000 70.53%
2024 193.119.000 -421.56%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

VIA Labs, Inc. Capital Expenditure
Year Capital Expenditure Growth
2016 7.385.000
2017 7.928.000 6.85%
2018 19.394.000 59.12%
2019 31.576.000 38.58%
2020 71.652.000 55.93%
2021 77.889.000 8.01%
2022 134.178.000 41.95%
2023 34.459.000 -289.38%
2023 165.209.000 79.14%
2024 20.420.000 -709.05%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

VIA Labs, Inc. Equity
Year Equity Growth
2015 353.854.000
2016 347.590.000 -1.8%
2017 592.990.000 41.38%
2018 716.976.000 17.29%
2019 866.802.000 17.28%
2020 2.616.871.000 66.88%
2021 3.201.770.000 18.27%
2022 3.180.924.000 -0.66%
2023 2.854.889.000 -11.42%
2023 2.862.768.000 0.28%
2024 2.914.930.000 1.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

VIA Labs, Inc. Assets
Year Assets Growth
2015 646.256.000
2016 600.950.000 -7.54%
2017 916.646.000 34.44%
2018 1.013.480.000 9.55%
2019 1.253.307.000 19.14%
2020 3.040.576.000 58.78%
2021 4.075.185.000 25.39%
2022 3.828.367.000 -6.45%
2023 3.604.963.000 -6.2%
2023 3.489.783.000 -3.3%
2024 3.841.250.000 9.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

VIA Labs, Inc. Liabilities
Year Liabilities Growth
2015 292.402.000
2016 253.360.000 -15.41%
2017 323.656.000 21.72%
2018 296.504.000 -9.16%
2019 386.505.000 23.29%
2020 423.705.000 8.78%
2021 873.415.000 51.49%
2022 647.443.000 -34.9%
2023 750.074.000 13.68%
2023 627.015.000 -19.63%
2024 926.320.000 32.31%

VIA Labs, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
28.12
Net Income per Share
2.72
Price to Earning Ratio
64.08x
Price To Sales Ratio
6.21x
POCF Ratio
13.98
PFCF Ratio
17.81
Price to Book Ratio
4.28
EV to Sales
5.67
EV Over EBITDA
36.57
EV to Operating CashFlow
12.77
EV to FreeCashFlow
16.26
Earnings Yield
0.02
FreeCashFlow Yield
0.06
Market Cap
12,14 Bil.
Enterprise Value
11,08 Bil.
Graham Number
50.01
Graham NetNet
14.14

Income Statement Metrics

Net Income per Share
2.72
Income Quality
4.25
ROE
0.07
Return On Assets
0.05
Return On Capital Employed
0.05
Net Income per EBT
0.89
EBT Per Ebit
1.56
Ebit per Revenue
0.07
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0.26
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.39
Operating Profit Margin
0.07
Pretax Profit Margin
0.11
Net Profit Margin
0.1

Dividends

Dividend Yield
0.01
Dividend Yield %
1.14
Payout Ratio
0.73
Dividend Per Share
2

Operating Metrics

Operating Cashflow per Share
12.48
Free CashFlow per Share
9.8
Capex to Operating CashFlow
0.21
Capex to Revenue
0.1
Capex to Depreciation
1.12
Return on Invested Capital
0.04
Return on Tangible Assets
0.05
Days Sales Outstanding
41.28
Days Payables Outstanding
46.41
Days of Inventory on Hand
39.92
Receivables Turnover
8.84
Payables Turnover
7.86
Inventory Turnover
9.14
Capex per Share
2.68

Balance Sheet

Cash per Share
24,13
Book Value per Share
41,90
Tangible Book Value per Share
39.71
Shareholders Equity per Share
40.81
Interest Debt per Share
3.5
Debt to Equity
0.09
Debt to Assets
0.06
Net Debt to EBITDA
-3.49
Current Ratio
2.26
Tangible Asset Value
2,76 Bil.
Net Current Asset Value
1,11 Bil.
Invested Capital
1449839000
Working Capital
1,14 Bil.
Intangibles to Total Assets
0.04
Average Receivables
0,20 Bil.
Average Payables
0,14 Bil.
Average Inventory
175043500
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

VIA Labs, Inc. Dividends
Year Dividends Growth
2020 3
2021 5 25%
2022 11 60%
2023 7 -42.86%
2024 2 -600%

VIA Labs, Inc. Profile

About VIA Labs, Inc.

VIA Labs, Inc. engages in the research, design, manufacture, and sale of USB and USB power delivery controllers for multi-functional devices and platforms in Taiwan. The company offers host, hub, and SATA bridge controllers; USB type-C products, including electronic markers, display port alternate mode products, USB data switches, USB audio products, and re-drivers; and power related IC products, such as USB-C DFP CC controllers, USB-C UFP CC controllers, and USB PD wall adapters and sink controllers, as well as USB4 endpoint devices and single stream transport video converters. It also provides contract testing, sales marketing support, integrated circuits chip testing, and technical support services. The company was founded in 1997 and is headquartered in New Taipei City, Taiwan. VIA Labs, Inc. is a subsidiary of VIA Technologies, Inc.

CEO
Yi-Jia Huang
Employee
176
Address
No. 529-1, Zhongzheng Road
New Taipei City, 231615

VIA Labs, Inc. Executives & BODs

VIA Labs, Inc. Executives & BODs
# Name Age
1 Yi-Jia Huang
Vice President
70
2 Xue-Zhong Lu
Vice President
70
3 Chin-Sung Hsu
Vice President
70

VIA Labs, Inc. Competitors